1. Market Research
  2. > Pathology
21 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • $ 2400
  • March 2018
  • 280 pages

Diffuse Large B Cell Lymphoma ##. ## Introduction ##. ## Classification of Diffuse Large B Cell Lymphoma ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027

  • $ 3300
  • June 2020
  • 1500 pages

Lymphoma (Million Cells/ Kg), May’2020 Figure ##-##: Kymriah - Annual Sales Value (US$ Million), 2017 - 2019 Figure ##-##: Global - Kymriah Quarterly Sales Value (US$ Million), 2019 Figure ##-##: Yescarta – FDA Approval & US Patent Expiration Year Figure ##-##: US – Yescarta Target

  • Biopharmaceutical
  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • World

Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026

  • $ 4000
  • February 2020
  • 600 pages

Lymphoma Treatment (Week), January’2020 Figure ##-##: Gazyva – Minimum & Maximum Treatment Cost of Follicular Lymphoma (US$), January’2020 Figure ##-##: Gazyva – Duration of Single Treatment Cycle & Full Treatment Using Monotherapy (Months), January’2020 Figure ##-##: Gazyv

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World
  • Supply

Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026

  • $ 2800
  • April 2019
  • 1200 pages

Lymphomas (US$), July 2018 Figure ##-##: US – Yescarta Target Dose vs Maximum Dose of CAR-positive viable T cells, October 2017 Figure ##-##: US - Yescarta & Kymriah Overall Treatment Cost (US$), April 2018 Figure ##-##: US - Yescarta & Kymriah Estimated Payment Rate by Centers for Medic

  • Cell Therapy
  • Lymphoma
  • Medical Biotechnology
  • United States
  • World

Global CAR T Cell Therapy Market Opportunity & Clinical Pipeline Insight 2024

  • $ 2800
  • November 2018
  • 400 pages

Global CAR T-Cell Therapy - Clinical Trials for Cancer Treatment ##. ## Acute Lymphoblastic Leukemia ##. ## Multiple Myeloma ##. ## Brain Tumors ##. ## Lymphoma ##. ## Solid Tumors ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy

Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026

  • $ 3000
  • May 2020
  • 510 pages

Role of ADCs in Cancer Management ##. ## Breast Cancer ##. ## Leukemia ##. ## Lymphoma ##. ## Other Cancers ##.

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026

  • $ 3300
  • June 2020
  • 753 pages

Small Molecule Drugs for Lymphomas – Availability, Dosage & Price Analysis ##. ## Copanlisib (Aliqopa) ##. ## Methoxsalen Solution (Uvadex) ##. ## Pralatrexate (Folotyn) ##. ## Bexarotene Topical (Targretin Gel) ##. ## Pixantrone (Pixuvri) ##. ## Belinostat (Beleodaq) ##. ## Zanubrutinib (Brukinsa) ##

  • Lymphoma
  • Therapy
  • World
  • Supply

Global Radioimmunotherapy Market, Dosage, Price & Clinical Pipeline Outlook 2022

  • $ 2400
  • March 2018
  • 200 pages

While it has already been approved as a standard treatment for Non Hodgkin Lymphoma and follicular lymphoma, it has yet to prove its clinical efficacy in other cancer types.

  • General Medicine And Specialty Medicine
  • Lymphoma
  • Oncology
  • Therapy
  • World

Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022

  • $ 2200
  • February 2018
  • 160 pages

Lymphoma ##. ## Neuroendocrine Tumors ##. ## Hepatocellular Carcinoma ##. ## Glioblastoma (Brain Tumor) ##. ## Other Cancers/ Tumors Where mTOR Inhibitors Could be Effective ##. ##. ## Non-small Cell Lung Cancers ##. ##. ## Colon Cancer ##.

  • Lymphoma
  • Targeted Therapy
  • Therapy
  • World
  • Demand

Global CAR T Cell Therapy Market & Clinical Trials Insight 2022

  • $ 2400
  • April 2017
  • 240 pages

Global CAR T Cell Therapy Clinical Trials for Cancer Treatment ##. ## Acute Lymphoblastic Leukemia ##. ## Multiple Myeloma ##. ## Brain Tumors ##. ## Lymphoma ##. ## Solid Tumors ##.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • $ 2400
  • February 2018
  • 225 pages

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 ##.

  • Cancer
  • Lymphoma
  • Oncology
  • Therapy
  • World

Global T Cell Lymphoma Market & Clinical Pipeline Insight

  • $ 1800
  • March 2016
  • 168 pages

Lymphoma Figure ##-##: Major Type of T-Cell Lymphoma Figure ##-##: Type of Anaplastic Large Cell Lymphoma Figure ##-##: Type of Uncommon T-Cell Lymphomas Figure ##-##: Extracorporeal Photopheresis (ECPP) Figure ##-##: Mechanism of Bexarotene Figure ##-##: Mechanism of Pralatrexate Figure ##-##:

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • Forecast

Global Nano Chemotherapy Market & Clinical Trials Outlook 2022

  • $ 1500
  • May 2017
  • 110 pages

Global Nano Chemotherapy Market & Clinical Trials Outlook 2022 ##.

  • Lymphoma
  • Therapy
  • World

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022

  • $ 2400
  • April 2017
  • 280 pages

Mostly hematological malignancies like follicular lymphoma, chronic lymphocytic leukemia and diffuse large B cell non-Hodgkin’s lymphoma have remained the focal point.

  • Cancer Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Histone Deacetylase Inhibitors Market & Pipeline Insight2015

  • $ 1800
  • August 2015
  • 180 pages

Besides, Vorinostat and Istodax there is another drug for lymphoma called Beleodaq is available in this segment.

  • Lymphoma
  • Pathology
  • Therapy
  • World

US Blood Cancer Drug Market & Pipeline Analysis 2015

  • $ 3000
  • July 2015
  • 1100 pages

Lymphoma Drug Clinical Pipeline by Company & Phase ##. ## Research till Registered ##. ## Discontinued & Suspended Lymphoma Drug Clinical Insight ##.

  • Cancer
  • Leukemia
  • Lymphoma
  • Pathology
  • United States

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

  • $ 2400
  • November 2014
  • 600 pages

Cutaneous B-Cell Lymphoma Clinical Pipeline Insight by Phase, Indication, Company & Country ##. ## Phase: Preclinical ##.

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • Forecast

Global Antibody Drug Conjugate Market & Pipeline Insight2020

  • $ 2000
  • August 2015
  • 350 pages

Global Antibody Drug Conjugate Market & Pipeline Insight2020 ##.

  • Cancer
  • Lymphoma
  • Medical Biotechnology
  • Pathology
  • Therapy

Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022

  • $ 2400
  • March 2017
  • 222 pages

Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022 ##.

  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • World

Global Radiopharmaceuticals Market Insight

  • $ 2200
  • February 2014
  • 450 pages

It is expected that over the next ##-## years horizon, this market would witness a steep increase owing to the introduction of many new products for treating lymphoma, colon cancer, lung cancer, prostate cancer, bone cancer and other persistent cancers.

  • Cancer
  • Lymphoma
  • United States
  • World
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on